Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources CLINICAL NUCLEAR MEDICINE Spratt, D. E., Zaki, B. I., Franc, B. L., Hartford, A. C., Osborne, J. R. 2016; 41 (2): 106–17

Abstract

This practice parameter is intended to guide appropriately trained and licensed physicians performing therapy with unsealed radiopharmaceutical sources. Such therapy requires close cooperation and communication between the physicians who are responsible for the clinical management of the patient and those who administer radiopharmaceutical therapy and manage the attendant side effects. Adherence to this practice parameter should help to maximize the efficacious use of these procedures, maintain safe conditions, and ensure compliance with applicable regulations. The goal of therapy with unsealed radiopharmaceutical sources is to provide either cure or effective palliation of disease while minimizing untoward side effects and complications.

View details for DOI 10.1097/RLU.0000000000001036

View details for Web of Science ID 000368629600017

View details for PubMedID 26646993